Effects of dopamine antagonism on methamphetamine sensitization: Evaluation by ambulatory activity in mice

[1]  H. Kuribara,et al.  [Modification of the behavioral effects of drugs after repeated administration--special reference to the reverse tolerance of amphetamines]. , 1990, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

[2]  T. Robinson,et al.  Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis , 1986, Brain Research Reviews.

[3]  R. Mailman,et al.  SCH-23390: a selective D1 dopamine antagonist with potent D2 behavioral actions. , 1984, European journal of pharmacology.

[4]  H. Kuribara,et al.  Circadian variation in susceptibility to methamphetamine after repeated administration in mice , 1984, Pharmacology Biochemistry and Behavior.

[5]  A. Barnett,et al.  SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. , 1983, The Journal of pharmacology and experimental therapeutics.

[6]  H. Maeno,et al.  Selective binding of YM-09151-2, a new potent neuroleptic, to D2-dopaminergic receptors. , 1983, Japanese journal of pharmacology.

[7]  H. Kuribara,et al.  Circadian variation in methamphetamine- and apomorphine-induced increase in ambulatory activity in mice , 1982, Pharmacology Biochemistry and Behavior.

[8]  S. Tadokoro,et al.  [Simple and easy method for measurement of ambulatory activity in mice (author's transl)]. , 1978, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

[9]  H. Kuribara,et al.  Reverse tolerance to the ambulation-increasing effect of methamphetamine in mice as an animal model of amphetamine-psychosis. , 1986, Psychopharmacology bulletin.